Kolexia
Narciso Berengere Oncologie médicale
Narciso Berengere
Oncologie médicale
Centre hospitalier de Tours
Tours, France
93 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Néphrocarcinome Sarcomes Carcinomes Tumeurs du cerveau Constipation Douleur cancéreuse Chordome Constipation induite par les opioïdes Anémie

Collaborateurs

Voir plus
Arnaud-Coffin Patrick
Arnaud-Coffin Patrick
Hôpital Fleyriat, Bourg-en-Bresse, France
Ulusakarya Ayhan
Ulusakarya Ayhan
Hôpital Paul Brousse, Villejuif, France
Hacini Maya
Hacini Maya
Hôpital Chambéry, Chambéry, France
Assi Fadi
Assi Fadi
Centre Hospitalier de Abbeville, Abbeville, France

Industries

Voir plus
A+A
514 collaboration(s)
Dernière en 2023
IQVIA
411 collaboration(s)
Dernière en 2023
P\S\L Group Services
325 collaboration(s)
Dernière en 2023
B3TSI
321 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
ORHEO: Role of biOsimilaRs in Therapeutic Management of Anemia Following Chemotherapy in HEmatology and Oncology; A Prospective, Observational, Non-interventional Study
Essai Clinique (Pfizer)   26 février 2024
StrateGlio: Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Essai Clinique (Centre Oscar-Lambret)   08 février 2024
Improved nationwide survival of sarcoma patients with a network of reference centers.
Annals of oncology : official journal of the European Society for Medical Oncology   19 janvier 2024
1971P Metastatic osteosarcoma, patterns of care and outcomes of patients in a real-life setting: The Metabone national observational study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1968P Metastatic Ewing sarcoma, patterns of care and outcomes of patients in a real-life setting: The Metabone national observational study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
1970P Metastatic chondrosarcoma, patterns of care and outcomes of patients in a real-life setting: The Metabone national observational study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Regorafenib in patients with relapsed advanced or metastatic chordoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre phase II study.
ESMO open   06 juin 2023
L’intensification du traitement du cancer de la prostate métastatique hormonosensible (MHSPC) est devenue un standard de prise en charge en France (étude profile)
116e congrès français d'urologie   01 novembre 2022
1468P IO-synthesise RCC: Real-world outcomes of nivolumab in patients (pts) with previously treated advanced non-clear cell renal cell carcinoma (nccRCC) – A pooled analysis from France and Germany
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
AxiPRO: A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanced Renal Cell Carcinoma Treated With Axitinib/Pembrolizumab in First Line
Essai Clinique (Weprom)   02 mai 2022